市場調查報告書

Asparaginase的全球市場:各類型(大腸菌來源,Erwinia Chrysanthemi來源,PEG化),各用途(醫療,食品產業,其他),各地區的市場規模與預測(2019年∼2026年)

Global Asparaginase Market Size study, by Type (Escherichia Coli, Erwinia Chrysanthemi, Pegylated) by Application (Healthcare, Food Industry, Others) and Regional Forecasts 2019-2026

出版商 Bizwit Research & Consulting LLP 商品編碼 931215
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Asparaginase的全球市場:各類型(大腸菌來源,Erwinia Chrysanthemi來源,PEG化),各用途(醫療,食品產業,其他),各地區的市場規模與預測(2019年∼2026年) Global Asparaginase Market Size study, by Type (Escherichia Coli, Erwinia Chrysanthemi, Pegylated) by Application (Healthcare, Food Industry, Others) and Regional Forecasts 2019-2026
出版日期: 2020年04月01日內容資訊: 英文
簡介
成為

Asparaginase,是為了將L-天門冬素水解為L-天冬氨酸和氨的催化劑的酵素,由大腸菌和Erwinia Chrysanthemi等細菌分離。Asparaginase,由於阻礙癌細胞的蛋白質合成,用於急性淋巴芽球性白血病(ALL),急性骨髓性白血病(AML),非何杰金氏淋巴瘤的治療。還有食品產業也使用於抑制含澱粉的食品中致癌性物質丙烯醯胺的形成,預計今後需求也將擴大。

本報告提供全球Asparaginase市場調查,市場力學,產業分析,各類型,各用途,各地區的分析,主要企業的簡介等資訊。

第1章 摘要整理

  • 市場概述
  • 全球市場和各市場區隔的估計與預測(2017年∼2026年)
  • 主要的趨勢
  • 估計的方法
  • 調查的前提條件

第2章 市場定義和範圍

  • 調查的目的
  • 市場定義和範圍
    • 調查範圍
    • 產業的演進
  • 調查對象期間
  • 貨幣換算比率

第3章 市場力學

  • 影響分析(2018年∼2026年)
    • 促進市場成長的要素
    • 市場課題
    • 市場機會

第4章 產業分析

  • 波特的五力分析
    • 供應商談判力
    • 買主談判力
    • 新加入廠商勢力的威脅
    • 替代品的威脅
    • 企業間競爭
    • 對五力分析模型的未來方法(2016年∼2026年)
  • PEST分析
    • 政治
    • 經濟
    • 社會
    • 技術
  • 投資採用模式
  • 分析師的建議與結論

第5章 市場分析:各類型

  • 市場概述
  • 市場的成果與未來性分析
  • 市場估計與預測
  • 子區隔分析
    • 大腸菌來源
    • Erwinia Chrysanthemi來源
    • PEG化

第6章 市場分析:各用途

  • 市場概述
  • 市場的成果與未來性分析
  • 市場估計與預測
  • 子區隔分析
    • 醫療
    • 食品產業
    • 其他

第7章 地區市場分析

  • 地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 南美
    • 巴西
    • 墨西哥
  • 其他

第8章 競爭資訊

  • 主要市場策略
  • 企業簡介
    • Jazz Pharmaceuticals
    • Shire
    • Medac GmbH
    • Kyowa Hakko Kirin Pvt. Ltd.
    • Qianhong Bio-pharma
    • Taj Pharmaceuticals
    • Mingxing Pharma
    • Exova SL Pharma Inc SL Pharma
    • United Biotech Pvt. Ltd Novus Biologicals

第9章 調查流程

  • 調查流程
    • 資料探勘
    • 分析
    • 市場預測
    • 檢驗
    • 出版
  • 調查的屬性
  • 調查的前提
目錄

Global Asparaginase Market is valued approximately at USD XXX million in 2018 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2019-2026. Asparaginase is an enzyme which catalzes the hydrolysis of l-asparagine to l-aspartic acid and ammonia. Asparaginase products are isolated from different types of bacteria, namely Escherichia coli and Erwinia chrysanthemi. They inhibit protein synthesis in tumor cells by depriving them of the amino acid asparagine. These are used widely in Healthcare industry and Food manufacturing industry as a medication. It is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available. As Asparaginase was approved for medical use in the United States in 1978. It is also on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. Asparaginase is used in the food manufacturing to reduce the formation of acrylamide. Acrylamide is a carcinogen in the starch containing food products such as biscuits and snacks. Thus, the rapidly growing healthcare and food manufacturing industry increase the demand for Asparaginase during the forecast period. As the Food and drinks market in Europe contributed to be the largest manufacturing sector in 2017 with a turnover of USD 1222 billion. The same sector invested USD 3.12 billion in research & development in 2017 which shows a positive sign in the market growth. Further, the rising investments of the market players for the research and development and production of Asparaginase according to the regulatory specification due to the rise in demand further fuels the market growth. However, the side effects of Asparaginase on human body such as mild bone marrow suppression, pancreatitis, anticoagulant factor resulting in stroke and bleeding hinders the market growth.

The regional analysis of global Asparaginase market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the dominant pharmaceutical industry in the region which is the major industry which uses Asparaginase enzyme. Further rising cases of Leukemia in the region propel the market growth. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as increasing population along with increasing disposable income coupled with growing food manufacturing industry would create lucrative growth prospects for the Asparaginase market across Asia-Pacific region.

Major market player included in this report are:

Jazz Pharmaceuticals Plc

Shire Plc

Medac GmbH

Kyowa Hakko Kirin Co., Ltd.

Qianhong Bio-pharma

Taj Pharmaceuticals

Mingxing Pharma

Exova SL Pharma Inc

United Biotech Pvt. Ltd.

Novus Biologicals

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Escherichia Coli

Erwinia Chrysanthemi

Pegylated

By Application:

Healthcare

Food Industry

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2016, 2017

Base year - 2018

Forecast period - 2019 to 2026

Target Audience of the Global Asparaginase Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investor

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
    • 1.2.1. Asparaginase Market, by Region, 2017-2026 (USD Billion)
    • 1.2.2. Asparaginase Market, by Type, 2017-2026 (USD Billion)
    • 1.2.3. Asparaginase Market, by Application, 2017-2026 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Asparaginase Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Asparaginase Market Dynamics

  • 3.1. Asparaginase Market Impact Analysis (2018-2026)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Asparaginase Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Asparaginase Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Asparaginase Market by Type, Performance - Potential Analysis
  • 5.3. Global Asparaginase Market Estimates & Forecasts by Type 2016-2026 (USD Billion)
  • 5.4. Asparaginase Market, Sub Segment Analysis
    • 5.4.1. Escherichia Coli
    • 5.4.2. Erwinia Chrysanthemi
    • 5.4.3. Pegylated

Chapter 6. Global Asparaginase Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Asparaginase Market by Application, Performance - Potential Analysis
  • 6.3. Global Asparaginase Market Estimates & Forecasts by Application 2016-2026 (USD Billion)
  • 6.4. Asparaginase Market, Sub Segment Analysis
    • 6.4.1. Healthcare
    • 6.4.2. Food Industry
    • 6.4.3. Others

Chapter 7. Global Asparaginase Market, Regional Analysis

  • 7.1. Asparaginase Market, Regional Market Snapshot
  • 7.2. North America Asparaginase Market
    • 7.2.1. U.S. Asparaginase Market
      • 7.2.1.1. Type breakdown estimates & forecasts, 2016-2026
      • 7.2.1.2. Application breakdown estimates & forecasts, 2016-2026
    • 7.2.2. Canada Asparaginase Market
  • 7.3. Europe Asparaginase Market Snapshot
    • 7.3.1. U.K. Asparaginase Market
    • 7.3.2. Germany Asparaginase Market
    • 7.3.3. Rest of Europe Asparaginase Market
  • 7.4. Asia-Pacific Asparaginase Market Snapshot
    • 7.4.1. China Asparaginase Market
    • 7.4.2. India Asparaginase Market
    • 7.4.3. Japan Asparaginase Market
    • 7.4.4. Rest of Asia Pacific Asparaginase Market
  • 7.5. Latin America Asparaginase Market Snapshot
    • 7.5.1. Brazil Asparaginase Market
    • 7.5.2. Mexico Asparaginase Market
  • 7.6. Rest of The World Asparaginase Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Jazz Pharmaceuticals
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Shire
    • 8.2.3. Medac GmbH
    • 8.2.4. Kyowa Hakko Kirin Pvt. Ltd.
    • 8.2.5. Qianhong Bio-pharma
    • 8.2.6. Taj Pharmaceuticals
    • 8.2.7. Mingxing Pharma
    • 8.2.8. Exova SL Pharma Inc SL Pharma
    • 8.2.9. United Biotech Pvt. Ltd Novus Biologicals

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL ASPARAGINASE MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL ASPARAGINASE MARKET
  • TABLE 3. GLOBAL ASPARAGINASE MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. GLOBAL ASPARAGINASE MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7. GLOBAL ASPARAGINASE MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD BILLION)
  • TABLE 8. GLOBAL ASPARAGINASE MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)
  • TABLE 9. GLOBAL ASPARAGINASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 10. GLOBAL ASPARAGINASE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 11. GLOBAL ASPARAGINASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12. GLOBAL ASPARAGINASE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13. GLOBAL ASPARAGINASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14. GLOBAL ASPARAGINASE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15. GLOBAL ASPARAGINASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16. GLOBAL ASPARAGINASE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17. GLOBAL ASPARAGINASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18. GLOBAL ASPARAGINASE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19. U.S. ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20. U.S. ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 21. U.S. ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 22. CANADA ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 23. CANADA ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 24. CANADA ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 25. UK ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 26. UK ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 27. UK ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 28. GERMANY ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 29. GERMANY ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 30. GERMANY ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 31. ROE ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 32. ROE ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 33. ROE ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 34. CHINA ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 35. CHINA ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 36. CHINA ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 37. INDIA ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 38. INDIA ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 39. INDIA ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 40. JAPAN ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 41. JAPAN ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 42. JAPAN ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 43. ROAPAC ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 44. ROAPAC ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 45. ROAPAC ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 46. BRAZIL ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 47. BRAZIL ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 48. BRAZIL ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 49. MEXICO ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 50. MEXICO ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 51. MEXICO ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 52. ROLA ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 53. ROLA ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 54. ROLA ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 55. ROW ASPARAGINASE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 56. ROW ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 57. ROW ASPARAGINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

  • FIG 1. GLOBAL ASPARAGINASE MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL ASPARAGINASE MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL ASPARAGINASE MARKET, KEY TRENDS 2018
  • FIG 5. GLOBAL ASPARAGINASE MARKET, GROWTH PROSPECTS 2019-2026
  • FIG 6. GLOBAL ASPARAGINASE MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL ASPARAGINASE MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL ASPARAGINASE MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL ASPARAGINASE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 10. GLOBAL ASPARAGINASE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 11. GLOBAL ASPARAGINASE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 12. GLOBAL ASPARAGINASE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 13. GLOBAL ASPARAGINASE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 14. GLOBAL ASPARAGINASE MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 15. NORTH AMERICA ASPARAGINASE MARKET 2016 & 2026 (USD BILLION)
  • FIG 16. EUROPE ASPARAGINASE MARKET 2016 & 2026 (USD BILLION)
  • FIG 17. ASIA PACIFIC ASPARAGINASE MARKET 2016 & 2026 (USD BILLION)
  • FIG 18. LATIN AMERICA ASPARAGINASE MARKET 2016 & 2026 (USD BILLION)
  • FIG 19. GLOBAL ASPARAGINASE MARKET, COMPANY MARKET SHARE ANALYSIS (2018)